Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ventyx Biosciences, Inc. (VTYX)  
$4.12 0.03 (0.73%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 50,296,000
Market Cap: 207.22(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.9 - $40.3
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ventyx Biosciences is a clinical-stage biopharmaceutical company engaged in the development of therapies for patients living with inflammatory diseases and autoimmune disorders. Co.'s product candidate is VTX958, an oral, selective clinical-stage tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis and Crohn's disease, among other potential indications. In addition, Co. is developing VTX002, an oral, selective sphingosine 1 phosphate receptor 1 modulator for ulcerative colitis. Co.'s oral, selective and peripherally restricted NLRP3 inhibitor, VTX2735, has been designed to treat systemic inflammatory diseases, such as cardiovascular, hepatic, renal and rheumatologic diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 9,019 90,800 3,592,266 6,036,052
Total Sell Value $48,733 $221,937 $56,317,001 $133,915,096
Total People Sold 4 4 7 8
Total Sell Transactions 4 7 60 103
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 178
  Page 4 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nsv Partners Iii Gp Llc 10% Owner   –       –       •   2023-06-14 4 S $35.08 $1,753,785 I/I (50,000) 9,787,045 55%     
   Subramaniam Somu Director   –       •       •   2023-06-14 4 S $35.08 $1,753,785 I/I (50,000) 9,787,045 55%     
   Subramaniam Somu Director   –       •       •   2023-06-07 4 S $35.48 $1,279,108 I/I (35,872) 9,837,045 47%     
   Nsv Partners Iii Gp Llc 10% Owner   –       –       •   2023-06-07 4 S $35.48 $1,279,108 I/I (35,872) 9,837,045 47%     
   Subramaniam Somu Director   –       •       •   2023-06-06 4 S $35.00 $144,481 I/I (4,128) 9,872,917 47%     
   Nsv Partners Iii Gp Llc 10% Owner   –       –       •   2023-06-06 4 S $35.00 $144,481 I/I (4,128) 9,872,917 47%     
   Auster Martin Chief Financial Officer   •       –      –    2023-06-06 4 AS $34.59 $969,963 D/D (28,000) 47,649 -47%     
   Auster Martin Chief Financial Officer   •       –      –    2023-06-06 4 OE $3.45 $96,600 D/D 28,000 75,649     -
   Nuss John Chief Scientific Officer   •       –      –    2023-06-05 4 AS $34.29 $343,467 D/D (10,000) 244,815 -43%     
   Nuss John Chief Scientific Officer   •       –      –    2023-06-05 4 OE $0.20 $2,000 D/D 10,000 254,815     -
   Mohan Raju Chief Executive Officer   •       •      –    2023-06-05 4 AS $34.32 $1,030,652 D/D (30,000) 1,513,126 -43%     
   Krueger Christopher W Chief Business Officer   •       –      –    2023-06-05 4 AS $34.31 $515,379 D/D (15,000) 276,548 -43%     
   Krueger Christopher W Chief Business Officer   •       –      –    2023-06-05 4 OE $0.20 $39,973 D/D 15,000 291,548     -
   Sandborn William J. See Remarks   •       –      –    2023-05-31 4 AS $34.26 $364,155 D/D (10,629) 48,389 -13%     
   Sandborn William J. See Remarks   •       –      –    2023-05-31 4 OE $0.20 $2,126 D/D 10,629 59,018     -
   Sandborn William J. See Remarks   •       –      –    2023-05-15 4 AS $36.09 $127,182 I/I (3,487) 34,662 -4%     
   Sandborn William J. See Remarks   •       –      –    2023-05-15 4 OE $0.20 $654 I/I 3,272 38,149     -
   Mohan Raju Chief Executive Officer   •       •      –    2023-05-05 4 AS $39.28 $1,178,502 D/D (30,000) 1,543,126 -12%     
   Krueger Christopher W Chief Business Officer   •       –      –    2023-05-03 4 AS $38.18 $579,699 D/D (15,000) 276,117 -11%     
   Krueger Christopher W Chief Business Officer   •       –      –    2023-05-03 4 OE $8.04 $120,600 D/D 15,000 291,117     -
   Nuss John Chief Scientific Officer   •       –      –    2023-05-03 4 AS $38.21 $386,371 D/D (10,000) 244,815 -11%     
   Nuss John Chief Scientific Officer   •       –      –    2023-05-03 4 OE $0.20 $2,000 D/D 10,000 254,815     -
   Sandborn William J. See Remarks   •       –      –    2023-04-28 4 AS $36.17 $398,755 D/D (10,790) 48,389 -11%     
   Sandborn William J. See Remarks   •       –      –    2023-04-28 4 OE $0.20 $2,158 D/D 10,790 59,179     -
   Auster Martin Chief Financial Officer   •       –      –    2023-04-25 4 AS $37.55 $1,064,990 D/D (28,000) 47,649 -10%     
  178 Records found
  1  2  3  4  5  6  7  8   
  Page 4 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us